Year: 2017
Type: article
Study design: Observational Study
Abstract: Introduction: Apoptotic genes regulate apoptosis by the action of their pro- and antiapoptotic products. Among the most important proteins are p53 and Bcl-2 proteins. The rate of tumor growth is dependent on the balance between proliferation and apoptosis at all stages of carcinogenesis. The differential expression of these apoptotic genes was analyzed in relation to clinicopathological criteria as Gleason Score in man with Prostate Cancer. Every prostate cancer patient who underwent histopathology examination which fulfill the criteria were included in the study. Samples then rearrange into low Gleason Score (2-6) and high Gleason Score (7-10). All samples then underwent gene expression assay for p53 and bcl-2 to be analyzed for each’s relationship with each group. The aim of this study was to evaluate tumor proliferation and the expression of the proto-oncogene Bcl-2 and tumor suppressor gene p53 in patients undergoing transurethral prostatectomy for prostate cancer, and to define their prognostic roles through correlation with final Gleason score, using qRTPCR.. A total of 40 samples consisting of 28 GS (2-6) and 12 GS (7-10) samples were included in the study. There was a significant mean difference between p53 mRNA in the GS 2-6 and 7-10 groups (p <0.001), but not for bcl-2 mRNA. Based on a multivariate analysis, only p53 mRNA had a significant association with the GS group in Adenocarcinoma Prostate with p = 0.014, 95% CI 0.926-0.991 with a predicted value of 77.5%. We conclude that p53 mRNA is an independent predictive factor of Gleason Score-based progression of adenocarcinoma Prostate.
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W2758716709
